Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
about
TIGAR is required for efficient intestinal regeneration and tumorigenesisMetabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with TemozolomideAlanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.Targeting cancer metabolism.Malignant behaviorial characteristics of CD133(+/-) glioblastoma cells from a Northern Chinese populationExtracellular RNA mediates and marks cancer progression.Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.Pediatric Gliomatosis Cerebri: A Review of 15 Years.Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7.Glutamate and α-ketoglutarate: key players in glioma metabolism.Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation.High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.Parallel evolution of IDH2 gene in cetaceans, primates and bats.Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI).
P2860
Q28585472-79DAB4F5-3497-4C53-ABA3-6417D276A6F1Q34318242-6CF1372B-AF09-4E26-B67E-6701A6326852Q36144444-A893D3D5-331A-445C-A611-C7D0866C5728Q36330869-433D72AC-6EB5-4B83-9940-451FC8C948CAQ36472345-B9FB2941-B676-40FB-893D-C15BD85F3E88Q38208372-9695CA06-8B83-479C-8E45-C36C55AA1526Q38405744-F6398696-8097-4D60-9B88-E70D8C6E4FADQ38560248-D99D90B9-46F8-45FD-88D0-00D6CE604CBCQ38755638-D2E8F3C7-4020-4E63-9244-C4ECC3A58182Q38820611-5B0B4AEB-22A4-490E-B002-04621EBF3AD6Q38983559-3FD2864D-A00A-46C3-A52E-13CA1685C783Q39271419-E81D8B79-4856-4044-B939-06E50A9D4288Q41670609-AD1E7D97-EAE8-408D-BE88-B36BA2AC087AQ42234896-0D01A7E9-4BCA-4734-84E8-9C0D3311E09BQ42738315-9F464DC3-C8F7-4BED-B68C-2ECA2C4494DAQ52601524-B8C1CAD7-4E8C-40D8-807E-8F820636EEEF
P2860
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@en
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@nl
type
label
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@en
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@nl
prefLabel
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@en
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@nl
P2093
P2860
P1476
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2.
@en
P2093
Alexandra Borodovsky
Gregory J Riggins
Meghan J Seltzer
P2860
P356
10.1097/CCO.0B013E32834D816A
P577
2012-01-01T00:00:00Z